ACGN — Aceragen Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $3.20m
- $1.08m
- $4.86m
Idera Pharma gains on acquiring Aceragen
Brief: Idera Pharmaceuticals Reports Qtrly Loss Per Share $0.10
Brief: Idera Pharmaceuticals Reports First Quarter 2022 Financial Results
Idera Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview
Idera Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Idera Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update
Idera Pharmaceuticals Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Booking Holdings, Galera Therapeutics, Chinese stocks
Brief: Idera Pharmaceuticals Inc Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Idera Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Idera Pharmaceuticals Posts Q3 Loss Per Share Of $0.11
Idera Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
Idera Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview
Idera Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Idera Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Idera Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Idera Pharma: Falls on discontinuing cancer treatment trial
Brief: Idera Pharmaceuticals Says Will Not Continue Illuminate-301 Trial
Idera Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary